Regulation of IkappaB beta in WEHI 231 mature B cells

R J Phillips1, S Ghosh

  • 1Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

Insights

Constitutive activation of Nuclear Factor-kappa B (NF-kappaB) in WEHI 231 cells involves hypophosphorylated IkappaB beta. This protein shields NF-kappaB from IkappaB alpha, enabling continuous nuclear import.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Constitutive Nuclear Factor-kappa B (NF-kappaB) activation in WEHI 231 B cells mirrors prolonged NF-kappaB activation seen in other stimulated cells.
  • In both scenarios, NF-kappaB DNA binding complexes persist in the nucleus despite high levels of cytosolic Inhibitor of kappa B alpha (IkappaB alpha).

Purpose of the Study:

  • To investigate the role of IkappaB beta in the constitutive activation of NF-kappaB in WEHI 231 B cells.
  • To elucidate the mechanism by which NF-kappaB remains active in the nucleus.

Main Methods:

  • Analysis of IkappaB beta phosphorylation status in WEHI 231 cells.
  • Detection of NF-kappaB and IkappaB beta complexes in both cytosol and nucleus.
  • Assessment of NF-kappaB DNA binding activity.

Main Results:

  • The predominant form of IkappaB beta in WEHI 231 cells is hypophosphorylated.
  • Hypophosphorylated IkappaB beta forms a stable complex with NF-kappaB in the cytosol.
  • This complex, containing NF-kappaB, is also found in nuclear DNA binding complexes.

Conclusions:

  • Hypophosphorylated IkappaB beta in WEHI 231 cells likely protects NF-kappaB from cytosolic IkappaB alpha.
  • This protection mechanism facilitates the continuous nuclear import of NF-kappaB, leading to its constitutive activation.